Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 12/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | FLT1 | P17948 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2932917 | 1.00 | — | — | |
| SCHEMBL46706 | 1.00 | AHR (1.00) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL47076 | 0.92 | AHR (1.00) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL30927171 | 0.92 | AHR (1.00) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL16426127 | 0.86 | AHR (0.74) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL10448864 | 0.86 | AHR (0.74) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL16426097 | 0.86 | AHR (0.74) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL10448868 | 0.86 | AHR (0.74) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL17876625 | 0.86 | AHR (0.79) | AHRLMNAMAPTHTTBLM | |
| SCHEMBL24277782 | 0.81 | AHR (0.70) | AHRLMNAMAPTHTTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112239452-B | Electron transport type heteroanthracene derivative and organic electroluminescent device thereof | 武汉尚赛光电科技有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-112239452-A | Electron transport type heteroanthracene derivative and organic electroluminescent device thereof | 武汉尚赛光电科技有限公司 | 2021-01-19 | — | — | CN | disclosed |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | DOOSAN SOLUS CO., LTD. (KR) | 2020-08-25 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | DOOSAN CORPORATION (KR) | 2017-06-15 | — | — | US | disclosed |
| WO-2017023126-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 | 2017-02-09 | — | — | WO | disclosed |
| WO-2015156580-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-10-15 | — | — | WO | disclosed |
| WO-2015156580-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-10-15 | — | — | WO | disclosed |
| WO-2015099438-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2015-07-02 | — | — | WO | disclosed |
| WO-2015099438-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2015-07-02 | — | — | WO | disclosed |
| US-8962779-B2 | Method of forming polyaryl polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-20150031847-A1 | METHOD OF FORMING POLYARYL POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2015-01-29 | — | — | US | disclosed |
| WO-2012003642-A1 | FUSED TRICYCLIC COMPOUNDS AND USE THEREOF FOR TREATING VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2012-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170170406-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | OR10J3, ORC3, L1CAM | AHR 3394/4885LMNA 2808/4885MAPT 1029/4885 |
| US-10756277-B2 | Organic compound and organic electroluminescent device comprising the same | OR10J3, L1CAM, ICOSLG | AHR 3072/4885LMNA 3036/4885MAPT 1006/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.